v3.26.1
Research and Development (Details Narrative) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Jul. 31, 2025
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development expenses $ 9,000 $ 104,000 $ 11,000 $ 151,000    
Accounts payable-license agreements - past due 3,167,000   $ 3,167,000   $ 3,167,000  
Research and developmentroyalty rates description     Under the amended agreements, royalty rates are structured as follows: 7% on the first $20 million of applicable net sales, 6% on sales between $20 million and $40 million, 5% on sales between $40 million and $100 million, and 4% on sales in excess of $100 million. These rates apply both during the initial term of the agreements and throughout the “Extended Term,” defined as a period of at least ten (10) years      
Revenues 0 $ 0 $ 0 0    
AOT Prototypes [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Research and development expenses     11,000 57,000    
License Agreements [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Accounts payable-license agreements - past due $ 3,167,000   3,167,000   $ 3,167,000 $ 3,167,000
Revenues     $ 0 $ 0    
License Agreements [Member] | A O T 1 Amendment 2 [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Total outstanding fees           2,236,000
License Agreements [Member] | A O T 2 Amendment 1 [Member]            
Research and Development Arrangement, Contract to Perform for Others [Line Items]            
Total outstanding fees           $ 931,000